Capital Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $519K | Sell |
1,280
-87
| -6% | -$35.3K | 0.01% | 449 |
|
|
2025
Q1 | $680K | Buy |
1,367
+32
| +2% | +$15.9K | 0.01% | 385 |
|
|
2024
Q4 | $695K | Buy |
1,335
+178
| +15% | +$92.6K | 0.01% | 367 |
|
|
2024
Q3 | $716K | Sell |
1,157
-1
| -0.1% | -$619 | 0.01% | 352 |
|
|
2024
Q2 | $641K | Sell |
1,158
-723
| -38% | -$400K | 0.01% | 357 |
|
|
2024
Q1 | $1.09M | Sell |
1,881
-34
| -2% | -$19.8K | 0.03% | 280 |
|
|
2023
Q4 | $1.02M | Sell |
1,915
-99
| -5% | -$52.5K | 0.03% | 274 |
|
|
2023
Q3 | $1.02M | Sell |
2,014
-11
| -0.5% | -$5.57K | 0.03% | 260 |
|
|
2023
Q2 | $1.06M | Sell |
2,025
-40
| -2% | -$20.9K | 0.03% | 236 |
|
|
2023
Q1 | $1.19M | Buy |
2,065
+92
| +5% | +$53K | 0.04% | 227 |
|
|
2022
Q4 | $1.09M | Buy |
1,973
+66
| +3% | +$36.3K | 0.03% | 241 |
|
|
2022
Q3 | $967K | Sell |
1,907
-2
| -0.1% | -$1.01K | 0.03% | 245 |
|
|
2022
Q2 | $1.04M | Buy |
1,909
+851
| +80% | +$462K | 0.03% | 243 |
|
|
2022
Q1 | $625K | Buy |
1,058
+6
| +0.6% | +$3.54K | 0.02% | 333 |
|
|
2021
Q4 | $702K | Buy |
1,052
+2
| +0.2% | +$1.34K | 0.02% | 328 |
|
|
2021
Q3 | $600K | Sell |
1,050
-60
| -5% | -$34.3K | 0.02% | 342 |
|
|
2021
Q2 | $560K | Buy |
1,110
+15
| +1% | +$7.57K | 0.02% | 352 |
|
|
2021
Q1 | $500K | Buy |
1,095
+2
| +0.2% | +$913 | 0.02% | 346 |
|
|
2020
Q4 | $509K | Buy |
1,093
+373
| +52% | +$174K | 0.02% | 331 |
|
|
2020
Q3 | $318K | Sell |
720
-14
| -2% | -$6.18K | 0.02% | 377 |
|
|
2020
Q2 | $266K | Hold |
734
| – | – | 0.01% | 403 |
|
|
2020
Q1 | $208K | Buy |
734
+65
| +10% | +$18.4K | 0.01% | 416 |
|
|
2019
Q4 | $217K | Buy |
+669
| New | +$217K | 0.01% | 472 |
|
|
2019
Q2 | – | Sell |
-740
| Closed | -$203K | – | 522 |
|
|
2019
Q1 | $203K | Buy |
+740
| New | +$203K | 0.01% | 453 |
|